Veradigm (MDRX) Stock Price, News & Analysis

Company Overview

Veradigm Inc. is a healthcare technology company that develops software, data, and connectivity solutions for healthcare providers, payers, pharmaceutical and life sciences companies, and other organizations across the healthcare ecosystem. The company’s offerings are designed to support clinical workflows, improve patient engagement, facilitate information exchange, and help organizations use healthcare data more effectively.

Its products and services include electronic health record and practice-management software, revenue-cycle management tools, e-prescribing and patient-engagement solutions, and analytics and data services. Veradigm also operates healthcare information networks and provides technology intended to connect providers, payers, and life sciences organizations for activities such as clinical research, quality improvement, and population health management.

The company was formerly known as Allscripts Healthcare Solutions and adopted the Veradigm name in 2023 as part of a broader effort to reflect its focus on connected healthcare technology and data-driven services. Veradigm primarily serves customers in the United States, with its solutions used across physician practices, hospitals and health systems, health plans, and life sciences organizations.

Key Stats

• Today's Range: $4.75 to $5.05
• 50-Day Range: $4.55 to $5.14
• 52-Week Range: $3.25 to $6.00
• Volume: 54,568 shs
• Average Volume: 123,789 shs
• Market Capitalization: $617.62 million
• P/E Ratio: 23.25
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/04/2021
• Today: 9/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:MDRX
• CIK: 1124804
• Web: veradigm.com
• Phone: (800) 334-8534
• Fax: 313-322-9600
• Employees: 8,000
• Year Founded: 1986

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 23.25
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.53 billion
• Price / Sales: 0.40
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 122,300,000
• Free Float: 105,175,000
• Market Cap: $617.62 million
• Optionable: No Data
• Beta: 0.56